Tosedostat
Showing 1 - 11 of 11
Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston (Azacitidine, Cytarabine, Tosedostat)
Terminated
- Acute Myeloid Leukemia
- High Risk Myelodysplastic Syndrome
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 9, 2020
Pancreatic Cancer, Cancer of Pancreas, Cancer of the Pancreas Trial in Saint Louis (Tosedostat, Capecitabine, Fresh tissue
Terminated
- Pancreatic Cancer
- +3 more
- Tosedostat
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 20, 2019
Myelodysplastic Syndrome Trial in New York (Tosedostat)
Completed
- Myelodysplastic Syndrome
- Tosedostat
-
New York, New YorkWeill Cornell Medical College
Jun 7, 2018
Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia
- +8 more
- tosedostat
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 13, 2017
Acute Myeloid Leukemia, AML Trial in Canada, Netherlands, United States (Tosedostat)
Completed
- Acute Myeloid Leukemia
- AML
- Tosedostat
-
Los Angeles, California
- +20 more
Jun 27, 2012
Healthy Trial in Evansville (CHR-2797)
Unknown status
- Healthy
-
Evansville, IndianaCovance Clinical Research Unit Inc.
Jul 18, 2012
NSCLC Trial in United States (CHR-2797 (tosedostat), erlotinib)
Terminated
- Carcinoma, Non-Small-Cell Lung
- CHR-2797 (tosedostat)
- erlotinib
-
Beverly Hills, California
- +6 more
Jun 27, 2012
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Edinburgh (CHR-2797 (tosedostat): Aminopeptidase
Completed
- Acute Myeloid Leukemia
- +2 more
- CHR-2797 (tosedostat): Aminopeptidase inhibitor
-
Edinburgh, Scotland, United KingdomNexus Oncology Ltd
Oct 21, 2010
Advanced Solid Tumors Trial (CHR-2797 (tosedostat))
Completed
- Advanced Solid Tumors
- CHR-2797 (tosedostat)
- (no location specified)
Aug 5, 2010